<DOC>
	<DOC>NCT00215280</DOC>
	<brief_summary>Mansonella perstans (M. perstans) infection is widespread in Uganda. Knowledge about the epidemiology of this infection, and of the morbidity it induces is poor, and no effective treatment is available. The study aims at providing data on diagnostic, epidemiological, morbidity and treatment aspects of M. perstans infections in Uganda.</brief_summary>
	<brief_title>Epidemiology and Control of Mansonella Perstans Infection in Uganda</brief_title>
	<detailed_description>Overall objective: to investigate diagnostic, epidemiological and treatment aspects of M. perstans in Uganda with relevance to control Specific objectives: 1. To establish the pattern of diurnal periodicity of M. perstans microfilaraemia in humans 2. To establish the patterns of M. perstans microfilaraemia and possible clinical manifestations related to this infection in two communities with medium to high endemicity 3. To determine the efficacy of ivermectin alone and the combination of ivermectin and albendazole on M. perstans microfilaraemia.</detailed_description>
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Lymphedema</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<mesh_term>Dipetalonema Infections</mesh_term>
	<mesh_term>Acanthocheilonemiasis</mesh_term>
	<mesh_term>Mansonelliasis</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<criteria>Individuals &gt;= 5 years with or without M. perstans infection Individuals &lt; 5 years Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Mansonella perstans</keyword>
	<keyword>microfilaraemia</keyword>
	<keyword>ivermectin</keyword>
	<keyword>albendazole</keyword>
	<keyword>Uganda</keyword>
</DOC>